Providing magnesium sulfate to pregnant patients before delivery in the periviable period of 22-24 weeks’ gestation was not linked to better neurodevelopmental outcomes in the newborn after accounting ...
Inadvertent administration of tranexamic acid instead of magnesium sulfate poses risks for thromboembolic complications and untreated seizures. A product mix-up has prompted Amneal to voluntarily ...
Intravenous (IV) administration of magnesium sulphate was associated with a reduced risk for in-hospital mortality and 30-day all-cause ICU mortality but possibly extended ICU and hospital stays among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results